Hibernating myocardium

American Journal of Critical Care

Volumn 10, Issue 2, 2001, Pages 84-93

  Brown, Theresa A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HEART; HEART LEFT VENTRICLE FUNCTION; HUMAN; MEDICAL EDUCATION; PATHOPHYSIOLOGY; REPERFUSION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUNNED HEART MUSCLE;

CORONARY DISEASE; ECHOCARDIOGRAPHY; EDUCATION, MEDICAL, CONTINUING; HEART; HUMANS; MYOCARDIAL STUNNING; REPERFUSION INJURY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0035293604     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2001.10.2.84     Document Type: Article

References (52)

1. Al-Mohammad A, Mahy IR, Norton MY, et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart. 1998;80:559-564.
2. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med. 1998;339:173-181.
3. Rahimtoola SH. Clinical aspects of hibernating myocardium. J Mol Cell Cardiol. 1996;28:2397-2401.
4. Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart. 2000;83:456-461.
5. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997-1004.
6. Sheiban I, Tonni S, Marini A, Trevi G. Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. Am J Cardiol. 1995;75:23E-30E.
7. Dispersyn GD, Ausma J, Thone F, et al. Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis. Cardiovasc Res. 1999;43:947-957.
8. Panza JA, Dilsizian V, Curiel RV, Unger EF, Laurienzo JM, Kitsiou AN. Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular function. J Nucl Cardiol. 1999;6:487-494.
9. Rahimtoola SH. Concept and evaluation of hibernating myocardium. Annu Rev Med. 1999;50:75-86.
10. Wallon S. Radionuclide techniques for myocardial viability and hibernation. Heart. 1999;81:6-7.
11. Knight C, Fox KM. The vicious circle of ischemic left ventricular dysfunction. Am J Cardiol. 1995;75(suppl):10E-15E.
12. DeNofrio D, Loh E. Myocardial viability in patients with coronary artery disease and left ventricular dysfunction: transplantation or revascularization? Curr Opin Cardiol. 1996;11:394-402.
13. Castro PF, Bourge RC, Foster RE. Evaluation of hibernating myocardium in patients with ischemic heart disease. Am J Med. 1998;104:69-77.
14. Rahimtoola SH. From coronary artery disease to heart failure: role of the hibernating myocardium. Am J Cardiol. 1995;75:16E-22E.
15. Camici PG, Wijns W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation. 1997;96:3205-3214.
16. Rahimtoola SH. Hibernating myocardium is hypoperfused. Basic Res Cardiol. 1997;92(suppl 2):9-11.
17. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
18. Hearse DJ. Myocardial ischemia: can we agree on a definition for the 21st century? Cardiovasc Res. 1994;28:1737-1744.
19. Akinboboye OO, Idris O, Cannon PJ, Bergmann SR. Usefulness of positron emission tomography in defining myocardial viability in patients referred for cardiac transplantation. Am J Cardiol. 1999;83:1271-1274.
20. Gunning MG, Chua TP, Harrington D, et al. Hibernating myocardium: clinical and functional response to revascularisation. Eur J Cardiothorac Surg. 1997;11:1105-1112.
21. Redwood SR, Ferrari R, Marber MS. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart. 1998;80:218-222.
22. Vanoverschelde JLJ, Pasquet A, Gerber B, Melin JA. Pathophysiology of myocardial hibernation: implications for the use of dobutamine echocardiography to identify myocardial viability. Heart. 1999;82(suppl 3):III1-III7.
23. Gallagher KP. Myocardial hibernation in terms of the flow-function relationship. Basic Res Cardiol. 1995;90:12-15.
24. Dispersyn GD, Borgers M, Flameng W. Apoptosis in chronic hibernating myocardium: sleeping to death? Cardiovasc Res. 2000;45:696-703.
25. Fath-Ordoubadi F, Beatt KJ, Spyrou N, Camici PG. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart. 1999;82:210-216.
26. Marinho NV, Keogh BE, Costa DC, et al. Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation. 1996;93:737-744.
27. Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation. 1996;94:651-659.
28. Maki M, Luotolahti M, Nuutila P, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation. 1996;93:1658-1666.
29. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning? Circ Res. 1995;76:479-488.
30. Elsassar A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931.
31. Schwarz ER, Schaper J, vom Dahl J, et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol. 1996;27:1577-1585.
32. Schwarz ER, Schoendube FA, Kostin S, et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol. 1998;31:1018-1026.
33. Walton J, Westrope P. Stunned myocardium: theoretical mechanisms of injury. Crit Care Nurse. April 1996;16:23-28.
34. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium." J Am Coll Cardiol. 1986;8:1467-1470.
35. Agati L, Autore C, Iacoboni C, et al. The complex relation between myocardial viability and functional recovery in chronic left ventricular dysfunction. J Am Coll Cardiol. 1998;81:33G-35G.
36. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart. 1998;79:281-288.
37. Pennell DJ, Ray SG, Davies G, et Al. The Carvedilol Hibernation Reversible Ischaemia Trial, Marker of Success (CHRISTMAS) study: methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure. Int J Cardiol. 2000;72:265-274.
38. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-670.
39. Burn S, Walters M, Caplin J. The hibernating heart: reversible left ventricular dysfunction in chronic heart failure. Postgrad Med J. 1999;75:419-421.
40. Bonow RO. The hibernating myocardium: identification of viable myocardium in patients with coronary artery disease and chronic left ventricular dysfunction. Basic Res Cardiol. 1995;90:49-51.
41. Naruse H, Kondo T, Arii T, et al. Comparative accuracy of various T1-201 reinjection imaging protocols to detect myocardial viability. Ann Nucl Med. 1996;10:119-126.
42. Inglese E, Brambilla M, Dondi M, et al. Assessment of myocardial viability after thallium-210 reinjection or rest-redistribution imaging: a multicenter study. J Nucl Med. 1995;36:555-563.
43. Adams JN, Norton M, Trent RJ, Mikecz P, Walton S, Evans N. Incidence of hibernating myocardium after acute myocardial infarction treated with thrombolysis. Heart. 1996;75:442-446.
44. Mariani MA, Palagi C, Donatelli F, et al. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction. Am J Card Imaging. 1995;9:1-8.
45. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
46. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation. 1996;94:2793-2799.
47. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1995;37:1022-1036.
48. Adams JN, Trent RJ, Norton M, Mikecz P, Walton S, Evans N. The persistence of hibernating myocardium after acute myocardial infarction. Eur Heart J. 1998;19:255-262.
49. Shivalkar B, Maes A, Borgers M, et al. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation. 1996;94:308-315.
50. Popock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
51. Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol. 1999;83:696-702.
52. Beattie S, Stapleton A. Noninvasive evaluation of coronary artery disease and myocardial viability through stress echocardiography and myocardial perfusion imaging. Nurse Pract. August 1997;22:32, 34, 39-40.